Sauer, Sandra http://orcid.org/0000-0001-5552-3149
Engelhardt, Monika http://orcid.org/0000-0003-0405-1676
Trautmann-Grill, Karolin
Kimmich, Christoph
Hänel, Mathias
Schmidt-Hieber, Martin
Salwender, Hans
Flossmann, Carmen
Heckmann, Hiltrud
Ertel, Franziska
Friederich, Andrea
Patel, Sachin
Thun, Barbara
Raab, Marc S. http://orcid.org/0000-0003-4181-6922
Funding for this research was provided by:
Amgen GmbH (Munich, Germany) and Amgen Europe GmbH (Rotkreuz, Switzerland).
Article History
Received: 14 August 2023
Revised: 5 January 2024
Accepted: 10 January 2024
First Online: 14 March 2024
Competing interests
: SS: Amgen: honoraria, research funding, travel support; Bristol Myers Squibb: honoraria; Janssen: honoraria, travel support; Sanofi: honoraria, travel support. ME: Amgen, Bristol Myers Squibb, Celgene, Janssen, Karyopharm, Novartis and Takeda: educational and trial support; Amgen, Bristol Myers Squibb, Celgene, Janssen, Novartis and Takeda: honoraria and consultancy fees. KTG: Amgen and Novartis: honoraria, research funding; GSK, Janssen, Sanofi and Takeda: honoraria. CK: Amgen: honoraria and research funding; GSK, Janssen and KiteGilead: honoraria and travel support; Sanofi-Aventis and Takeda: honoraria. MH: Amgen, Bayer Vital, Celgene, Gilead, GSK, Jazz Pharmaceuticals, Novartis, Roche, Sanofi, Sobi and Takeda: honoraria. MSH: Amgen GmbH, Bristol Myers Squibb GmbH & Co. KG, Celgene GmbH, GSK GmbH & Co. KG, Kite/Pharma Gilead, Sanofi-Aventis Deutschland GmbH, Shionogi GmbH and Stemline Therapeutics (no individual payment): consultancy, financial support of educational meetings; Celgene GmbH (no individual payment), Janssen-Cilag GmbH, Novartis Pharma GmbH, Pfizer Pharma GmbH, Roche Pharma AG, Takeda Pharma Vertrieb GmbH & Co. KG and Vifor Pharma Deutschland GmbH: financial support of educational meetings. HS: Amgen, Bristol Myers Squibb, Celgene, Janssen and Novartis: honoraria, travel support and research funding; Takeda: honoraria. MSR: Amgen, Bristol Myers Squibb and Novartis: consultancy, honoraria and research funding; Celgene: consultancy and honoraria. BT is an employee of IQVIA who received funding from Amgen to conduct this research study. CF, HH, FE and AF are employees of Amgen GmbH and hold Amgen stock. SP is an employee of Amgen Ltd and holds Amgen stock. This study was funded by Amgen (Germany and Europe) GmbH. Medical writing support was provided by Carine Thual of Amgen (Europe) GmbH.